INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
|
|
- Virgil Hensley
- 5 years ago
- Views:
Transcription
1 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF SUSTAINED RELEASE PELLETS OF BOSENTAN HCl SIDDHI V. PATEL 1,2, DR. MUKESH S. PATEL 2 1. Research scholar, Gujarat Technological University, Gujarat. 2. Department of Pharmaceutics, Shri B. M. Shah College of Pharmaceutical Education and Research, Modasa , Gujarat, India. Accepted Date: 10/04/2016; Published Date: 27/04/2016 Abstract: The objective of present study was develop Bosentan HCl pellets, sustained release Dosage form, for the treatment of pulmonary arterial hypertension Diseases. Drug Excipients Compatibility study was performed through FTIR and DSC revealed that there no interaction between drug and polymers. Pellets were prepared by Extrusion-Spheronization technique using different Concentration of HPMC K 100, Eudragit RS 100, and Eudragit RL 100. Prepared formulation was subjected to Evaluation parameter like Bulk density, Tapped density, Hausner ratio, Carr s index, Angle of repose, % yields of pellets, %drug loading, %Friability, Mean particle size. In vitro dissolution study in 0.1 N HCl (ph 1.2) for first 2 hours followed by phosphate buffer (ph 6.8) for remaining 10 hours. The optimized formulation batch (F6) on the basis of acceptable pellets properties and In vitro drug release study F6 batch was found to 99.1% drug release at 12 hour. The formulation meet the needed theoretical drug release profile and has the sustain action i.e. retarding the drug release so the release is for the long time. Keywords: Bosentan HCl, Sustained release pellets, Extrusion-spheronization, Eudragit RS 100, Eudragit RL 100 Corresponding Author: MS. SIDDHI V. PATEL Access Online On: PAPER-QR CODE How to Cite This Article: 124
2 INTRODUCTION Bosentan HCl is an antihypertensive drug. It is used as pulmonary arterial hypertension. It is endothelial receptor antagonist. The administered bosentan HCl is antihypertensive drug is BCS II So, it has low solubility and high permeability. Its half life is 5 hours. To require Prepared sustained release pellets of bosentan hcl and improves patient compliance and increase efficiency in the treatment. The oral route of administration for sustained release systems has received greater attention because of more flexibility in dosage form design.oral drug delivery has been known for decades as the most widely utilized route of administration. Conventional drug therapy typically involves the periodic dosing of a therapeutic agent conventional method of formulation is quite effective. Sustained release systems include any drug delivery system that achieves slow release of drug over an extended period of time. Sustained release dosage forms provide a better control of plasma drug level. Control release systems denotes systems which can provide some control whether this be of a temporal or partial nature or both of drug release in the body. The pellets can be utilized to provide a controlled release of drug. Pellets disperse freely in GIT so, maximum absorption of drug and reduce peak plasma fluctuation. To prepare sustained release pellets without coating by extrusion spheronization process is to produce pellets of uniform size with high drug loading capacity. Pellets are recommended for patient with difficulty in swallowing and dysphasia like in case of children and geriatrics patients. MATERIAL AND METHOD Materials Bosentan HCl was purchased from Alembic Pharmaceutical Ltd. Eudragit RS 100 and RL 100- Evonik degusa India Pvt. Ltd, Mumbai, Avicel PH 101- Chemodyes Corporation, PVP K 30- Tuton Pharma, Ahmedabad. Preliminary Studies Determination of λ max UV spectrophotometric study of Bosentan HCl was carried out to identify λ max of drug in 0.1 N HCl and 6.8 ph phosphate buffer. The prepared solution was scanned from 200 to 400 nm in UV spectrophotometer. The wavelength of the maximum absorption was noted and UV spectrum was recorded. 125
3 Standard calibration curve of Bosentan HCl A stock solution of Bosentan HCl of concentration 100µg/ml was prepared in 0.1 N HCl and 6.8 ph phosphate buffer. The calibration curves were constructed using standard solution in the range 2-16µg/ml diluted with appropriate solvent. The assignments were represented in Table.7, 8 and Figure. 7, 8. Drug Excipient Interaction Study FTIR of Bosentan HCl, Eudragit RS 100 and Eudragit RL 100 were recorded using KBr mixing method. Drug-excipient interactions play a vital role in the release of drug from formulation. The drug bosentan HCl and formulation previously ground and mixed thoroughly with KBr, an infrared transparent matrix, at 1:10 or 1:100 (sample: KBr) ratio respectively. The KBr discs were prepared by compressing the powders. The samples were scanned between cm-1. METHOD OF PREPARATION OF SUSTAINED RELEASE PELLETS In prepared the pellets by using Extrusion spheronization technique. Pellets was prepared batch F1-F9 with various concentration of Polymer (Eudragit RS 100, Eudragit RL 100).In the Factorial Study, Avicel PH 101 used as a spheronizing agent. In this study, (2%) PVP K 30 in water was used to prepared dump mass. All the Factorial formulation contains bosentan HCl as an active ingredient. Eudragit RL 100, Eudragit RS 100 are used to polymer (matrix forming agents). All ingredients were mixed in double cone minimixer. In above mixture 2 % PVP K-30 water was added to make dump mass. Prepare dump mass were subjected to undergoes to extrusion (using 1mm sieve) then, resultant extrudate was spheronized equipped with 4.2 mm friction plate at various rotational speed and time. Pellets were formed and collected in tray. Table 1: Formulation of SR pellets Factorial Batches (F1-F9) using 3 2 Full Factorial Designs Ingredients (%) FORMULATION BATCH CODE (%) F1 F2 F3 F4 F5 F6 F7 F8 F9 Bosentan HCl Eudragit RS Eudragit RL Avicel PH % PVP K-30 in Water q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. q.s. 126
4 Evaluation of pellets: 1) Loose Bulk Density: Weigh accurately 5 gm of pellets, and transferred in 100ml graduated cylinder. Carefully level the powder blend without compacting, and read the unsettled apparent volume (Vo). Calculate the apparent bulk density in gm/ml by the following formula: Bulk Density = Mass/apparent volume 2) Tapped Bulk Density: Weigh accurately 5 gm of pellets, and transferred in 100 ml graduated cylinder. Then mechanically tap the cylinder containing the sample by raising the cylinder and allowing it to drop under its own weight using mechanically tapped density tester that provides a fixed drop of 14 ± 2mm at a nominal rate of 300 drops per minute. Tap the cylinder for 500 times initially and measure the tapped volume (V1) to the nearest graduated units, repeat the tapping an additional 750 times and measure the tapped volume (V2) to the nearest graduated units. If the difference between the two volumes is less than 2% then final the volume (V2). Calculate the tapped bulk density in gm/ml by the following formula: Tapped Density = Mass/tapped volume 3) Carr s index: The Compressibility index of the pellets was determined by Carr s compressibility index. It is a simple test to evaluate the bulk density and tapped density of a pellets and the rate at which it packed down. The formula for Carr s index is as below: Carr s Index = Tapped Density-Bulk Density 100/ Tapped Density 4) Hauser s Ratio: The Hauser s ratio is a number that is correlated to the flow ability of a pellets material. Hauser s Ratio = Tapped density/bulk Density Table 2: Effect of Carr s index and Hausner s ratio and flow property Carr s index Flow Character Hauser s ratio 10 Excellent Good Fair Passable
5 26-31 Poor Very poor Very, Very poor ) Angle of Repose: The angle of repose of powder blend powder was determined by the funnel method. The pellets were taken in the funnel. The height of the funnel was adjusted in such a way the tip of the funnel just touched the apex of the pellets. The pellets were allowed to flow through the funnel freely on to the surface. he diameter of the pellets cone was measured and angle of repose was calculated using the using following Equation. Angle of Repose (Ø) = tan -1 (h/r) Where, h = Height of the pellets cone r = Radius of the pellets cone Table 3: Effect of angle of repose on flow property Angle of Repose Type of flow <20 Excellent Good Passable <35 Very poor 6) Particle size and size distribution: The particle size and size distribution of the pellets produced was determined by agitation for 10 min with a sieve shaker fitted with a progression of standard sieves. From the weight retained on each sieve particle size is determined from standard sieve aperture size as per Indian pharmacopeia. 7) % Friability: Accurately weight quantity of pellets 4 gm were taken from final batch of pellets and placed in a friabilator and tumbled for 100 revaluations at 25 rpm. Twelve steel balls (weighing gm each) were used as attrition agent. Subsequently, the pellets were sieved through sieve no. 20. The weight loss (%) is calculated as: % F= (Wi Wr/ Wi) 100 Where, Wi= initial weight of pellets before friability testing, and 128
6 Wr = the weight of pellets retained above the sieve after friability testing. 8) % Drug Loading: The pellets were crushed and the powder equivalent of 100 mg of drug was dissolved in 20 ml methanol and then transferred to100 ml of 0.1 N HCl in volumetric flask. The solution was analyzed at 247 nm using double beam UV-Vis spectrophotometer after suitable dilution. The content of drug was calculated from calibration curve. 9) % Practical yield: The percentage of production yield was calculated from the weight of dried pellets (w1) recovered from each of batches and the sum of the initial dry weight of starting materials (w2). The formula for calculation of percentage yield is as follows. % Practical yield = (practical value/ theoretical value) * ) In-Vitro Dissolution Study: The in vitro dissolution study of 62.5 mg equivalent weight of Bosentan HCl pellets were performed as described in USP type-i apparatus fitted with basket (100 rpm) at 37 o C ± using simulated gastric fluid (ph 1:2 700 ml) as a dissolution medium for first 2 hour and followed by phosphate buffer (ph ml) by adding 200 ml of 0.2 mol/l tri basic sodium phosphate in dissolution media for remaining hours. At the 1 hour time intervals, 10 ml samples were withdrawn, and analyzed at 247 nm in 0.1 N HCl and 247 nm in 6.8 phosphate buffer using a shimadzu UV 1800 double beam spectrophotometer (Shimadzu, Kyoto, Japan) Cumulative percentage drug release was calculated using an equation obtained from a calibration curve which is developed in the range of 2-16 µg/ml for 0.1 N HCl and ph 6.8 phosphate buffer. STABILITY STUDY Stability testing of drug products beings as a part of drug discovery and ends with the demise of the compound or commercial products. To assess the drug and formulation stability, stability studies were done according to ICH guideline Q1C. The stability studies were carried out on the most satisfactory formulation as per ICH guideline Q1C.The optimized formulation (F6) sealed in vial with rubber cap and kept in humidity chamber maintained 40±2 o C/75±5% RH for 1 month. At the end of studies, samples were analysed for the in vitro drug release study. Comparison of both batches was carried out using similarity factor (f2) and disimilarity factor (f1) and t Test: two samples assuming equal variance. 129
7 RESULT AND DISCUSSION Drug polymer compatibility studies The formulation contains Bosentan HCl, and Eudragit RS 100 and Eudragit RL 100. There is no significant difference observed in characteristic peaks of pure drug and drug excipients mixture. So it was indicated that drug was compatible with excipients. 100 %T bosentan HCl /cm Figure 1: FTIR Spectra of Bosentan HCl (Pure drug) Table 4: Frequency of Pure drug Functional group Reference Frequency of pure drug (cm -1 ) Aromatic C-H bond C-N Stretch N-H bend C-H Stretch C-Cl Stretch %T 95 formulation1 bosentan bosentan HCl formulation /cm Figure 2: FTIR Spectra of Bosentan HCl + Formulation 130
8 Table 5: FTIR spectra of pellets formulation Functional group Frequency cm -1 Pure drug Formulation Aromatic C-H bond C-N Stretch N-H bend C-H Stretch C-Cl Stretch Differential Scanning Calorimetry DSC thermogram study was performed for interaction between the drug and polymer. The drug and polymer were closely maintained at same temperature throughout the analysis. The DSC thermogram was showed peak for the drug, individually as well as in combination with polymers, which indicated that there was no significant interaction between the drug and polymers. Table 6: Interpretation of DSC spectral data Name of Substance Bosentan Drug + polymer Eudragit RL 100 Eudragit RS 100 Temperature o C o C o C o C o C o C Figure 3: DSC spectrum of Pure drug Bosentan HCl 131
9 Figure 4: DSC spectrum of Drug+ Formulation Figure 5: DSC spectrum of Eudragit RL 100 Figure 6: DSC spectrum of Eudragit RS
10 Absorbance Research Article CODEN: IJPRNK Impact Factor: ISSN: Analytical Results The calibration curve for bosentan was developed in 0.1 N HCl and phosphate buffer ph 6.8. A plot was obtained in the concentration range of 2-16µg/ml and the absorbance was measured at 247 nm. Table 7: Standard curve of Bosentan HCl in 0.1 N HCl Sr. No Conc. (µg/ ml) Absorbance Calibration curve of Bosentan HCl in 0.1 N HCl y = 0.055x R² = Sr. No Figure 7: Standard curve of Bosentan HCl in 0.1 N HCl at 247nm Table 8: Standard curve of Bosentan HCl in 6.8 ph phosphate buffer Conc. (µg/ml) Concentartion ( µg/ml) Average Absorbance 133
11 Absorbance Research Article CODEN: IJPRNK Impact Factor: ISSN: Calibration curve of Bosentan HCL in 6.8 phosphate buffer Concentration (µg/ml) y = 0.057x R² = Figure 8: Standard Calibration curve of Bosentan HCl in 6.8 ph Phosphate buffer EVALUATION PARAMETER Table 9: Flow properties of factorial batches (F1-F9) of pellets Batch code Bulk density ( g/cm 3 ) Tapped density ( g/cm 3 ) Hausner s Ratio Carr s Index (%) Angle repose (Degree) F1 0.67± ± ± ± ±1.39 F2 0.72± ± ± ± ±0.82 F3 0.65± ± ± ± ±2.12 F4 0.64± ± ± ± ±1.46 F5 0.76± ± ± ± ±1.46 F6 0.62± ± ± ± ±0.75 F7 0.74± ± ± ± ±0.56 F8 0.66± ± ± ± ±0.57 F9 0.70± ± ± ± ±1.87 of 134
12 Table 10: Evaluation Factorial batches (F1-F9) of pellets Batch code % yield of % Drug loading % friability Mean particle Size pellets (µm) F F F F F F F F F Table 11: In Vitro drug release studies of Factorial batches TIME (Hour) %CPR F1 F2 F3 F4 F5 F6 F7 F8 F In the factorial batches, different ratio Eudragit RS 100 and Eudragit RL 100 were used. In Vitro drug release profiles of the factorial batches are reported in the Table.11and Figure No.9. Results specify that drug release time was increased with increase the polymer concentration. In Vitro drug release profile of the factorial batches indicated that F1 batch shows 96.1 % drug release within 10 hour while F2 batches shows 97.4% drug release within 11 hour, F3 batch shows 96.9 % drug release within 12 hour, F4 batch shows 89.2% drug release within 10 hour, F5 batch shows 99.7% drug release within 11 hour, F6 batch shows 99.1% drug release within 12 hour, F7 batch shows 95.7% drug release within 12 hour, F8 batch shows 94.5% drug release within 12 hour, F9 batch shows 93.4% drug release within 12 hour. 135
13 % CPR Research Article CODEN: IJPRNK Impact Factor: ISSN: F1 - F9 batches Time (hour) F1 F2 F3 F4 F5 F6 F7 Figure 9: In vitro dissolution of F1-F9 batches RESPONSE SURFACE PLOT In the factorial design and different graphical representation of pellets were prepared using different ratio of polymer is X1 is a Eudragit RS 100 and X2 is Eudragit RL 100 was affected on t50(hr), t90(hr), Q2 (%), Q10 (%). As increase in concentration of Eudragit RS 100 and Eudragit RL 100, increase in t50 (hr) and Q2 (%) but decrease in t90 (hr) and Q10 (%). From the result of factorial batches (F1 F9), it can be reported that F6 batch (15% Eudragit RS 100 and 12.5 % Eudragit RL 100). Figure 10: Response surface plot of t50 136
14 Figure 11: Response surface plot of Q2 Figure 12: Response surface plot of t90 Figure 13: Response surface plot of Q10 137
15 KINETIC MODELING OF DISSOLUTION DATA The kinetics of the dissolution data were well fitted to zero order, Higuchi model and Korsemeyer Peppas model as evident from regression coefficients. The value of diffusion exponent (n) for F1 to F9 batches of factorial formulations were between to so it indicates fickian diffusion of the drug from formulation which corresponds to diffusion, erosion and swelling mechanism. Kinetic model Higuchi model shows that R 2 value F1 F9 batches were in range between to shows that drug release type was diffusion type from gel network and sustained drug release for longer period of time. Kinetic model zero order representing that R 2 value of F1 F9 batches were range in between to that near about clearly mentioned that drug release from stiff gel networking was zero order drug release that not depends on concentration of drug. Kinetic model first order shows that R 2 value of F1 F9 batches were in range between to which was less than the R 2 value of zero order drug release therefore the drug release type was dominant to zero order release from gel network which is reported in Table.12. Table 12: Kinetic modeling of dissolution data F1 F2 F3 F4 F5 F6 F7 F8 F9 Zero order S I R First order S I R Higuchi S I R Hixon Crowell S I R Korsemeyer and Peppas N I R S=slope, I=intercept, R 2 =square of correlation coefficient, n=diffusion exponent 138
16 COMPARISON OF DISSOLUTION PROFILES FOR SELECTION OF OPTIMUM BATCH The values of Dissimilarity factor (f1) and similarity factor (f2) for all batches were compared with theoretical dissolution profile (Table 5.22). it was indicated that F6 batch shows minimum value of f1 (3.58) and also showed maximum value of f2 (80.15). So it was revealed that F6 batch having less dissimilarity and good similarity with theoretical release profile. Table 13: Similarity factor (f2) and Dissimilarity (f1) of F1-F9 Batch Similarity factor (f2) Dissimilarity factor (f1) F F F F F F F F F Verification of model by check point batch Time (hour) CPR (%) Table 14: Dissolution of check point batch 139
17 Table 15: Evaluation parameter and in vitro dissolution of check point batch In vitro dissolution study Check t50 t90 Q2 Q10 point P O P O P O P O batch It can be observed that the predicted value and observed value of CP t50, t90, Q2, Q10 of SR pellets were nearly similar with 3 2 factorial design batches. It can be revealed that the evolved model can be used for prediction of response i.e. In vitro dissolution time of pellets within the simplex space. Here comparative analysis of the predicted value and experimental value using paired t test was carried out. It was shows that there was no significant difference between tcal (1.23) and ttab (3.18). Hence it complies the t test because of ttab values was higher than tcal. In the present research work, no more difference between factorial batches and one check point composition. ACCELERATED STABILITY STUDY Amongst all the nine batches, pellets of batch F6 have more desirable characteristics as the pellets of batch F6 gave about 99.1 % of drug release in 12 hrs. Having Q2 value of 41.8% drug release in 2 hrs and Q10 value of 93.1% drug release in 10 hrs showing sustained release formulation. Hence the pellets batch F6 have considered as promising batch for accelerated stability study. From results of accelerated stability study, it was observed that the pellets of batch F6 was stable for period of 1 month at 40 o C/75%RH. The f1 value found was (3.58) and f2 value found was (80.15) respectively for dissolution profile of pellets after 30 days of storage comparing with the dissolution profile of freshly prepared formulation. The f1 and f2 Value was in range of 0-15 and respectively indicating similarity between two dissolution profiles. Table 16: In vitro dissolution data of F6 batch after accelerated stability study Time (hrs) CPR CPR (After 30 days) Time (hrs) CPR CPR (After 30 days)
18 CONCLUSION In the Present Research work, attempt has been made to formulation and evaluation of Sustained Release Pellets Bosentan HCl. FTIR spectroscopy revealed that there was no chemical interaction between drug and polymer so; drug is compatible with polymer. DSC thermogram study was performed for interaction between the drug and polymer. It was showed peak for the drug, individually as well as in combination with polymers, which indicated that there was no significant interaction between the drug and polymers. As increase in concentration of Eudragit RS 100 and Eudragit RL 100, increase in t50 (hr) and Q2 (%) but decrease in t90 (hr) and Q10 (%). From the result of factorial batches (F1 F9), it can be reported that F6 batch (15% Eudragit RS 100 and 12.5 % Eudragit RL 100) shows 99.1% drug release at 12 hours. Comparative analysis of the predicted value and experimental value using t test revealed that there was no significant difference between the two values thereby establishing validity of generated mode of in vitro dissolution time of pellets with one check point composition. Various kinetic models confirmed that In vitro release kinetic of optimize batch (F6) was followed diffusion and erosion mechanism and n value indicates non fickian behaviour with mixed order drug release pattern. Finally, we can conclude that formulation and evaluation of sustained release pellets was successfully completed so, It will be used for the large scale production. REFERENCE 1. Patidar S and Chauhan BP, Oral sustained release dosage form: A Review. J. of drug discovery and therapeutic. 2013, 1(12), Chugh I, Seth N, Rana AC, Gupta S, A Review On: Oral Sustained Release Drug Delivery. Int. Res. J.Pharm. 2012, 3(5), Bhargava A, Rathore RSP, Tanwar YS, Gupta S, Bhaduka G, Oral Sustained Release Dosage Form: An Opportunity to Prolong the Release of Drug. Int J. Advanced Res. Pharm. Bio. Sci Gupta MM and Ray B, A Review on: Sustained release technology. Int. J. of therapeutic application, 2012, 8, Costa P, Manuel J and Labao S, Modeling and Comparison of dissolution profiles. Euro. J. Pharm. Sci. 2002, 13,
19 6. Moore Jw and Flanner HH, Mathematical comparison of dissolution profiles. Pharm. Techno. 1996, 20(6), Dr. Yi Cheng. The response surface methodology, 2nd Edn; Nuran Bradley, 2007, pp Rojas FS, Ojeda Cb, Sanchez AJR and Bosch ME, Use of Experimental Design for Calibration and Validation of Ascorbic acid and Citric acid Mixtures. J. Mex. Chem. Soc. 2008, 52(4), ICH Q1A (R2) Guideline, Stability testing of new drug substance and products. January AR2%20C.pdf 142
Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP
161 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP 162 Chapter 7 FORMULATION AND CHARACTERIZATION OF PULSINCAP S.No. Name of the Sub-Title Page No. 7.1. Optimization of formulations of Pulsincap
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE DEVELOPMENT OF VALIDATED UV SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF BETAXOLOL HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM SIDHARTH
More informationCHAPTER-3 MATERIALS AND METHODS
75 CHAPTER-3 MATERIALS AND METHODS 76 3.1 MATERIALS 3.1.1 Drugs used in the present study Lamivudine Zidovudine Stavudine Drug name Source Alchem laboratories, Mumbai, India 3.1.2 Excipients and chemicals
More information9. Gastroretentive beads (GRBs) 9.1. Preparation of GRBs
9. Gastroretentive beads (GRBs) 9.1. Preparation of GRBs Beads were prepared by ionotropic gelation method using sodium alginate and calcium chloride as per previously reported (Dhalleine et al., 2011;
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF DILTIAZEM HYDROCHLORIDE BY MELT GRANULATION TECHNOLOGY
More informationFormulation and evaluation of matrix tablets of Famotidine using hydrophilic polymer
Available online at www.scholarsresearchlibrary.com Scholars Research Library Archives of Applied Science Research, 2010, 2 (3):212-220 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-508X
More informationPreparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 193-197, Jan-Mar 2013 Preparation And Characterization Of Simvastatin Nanosuspension By Homogenization Method
More informationResearch Article. Dissolution Study of Oxolamine Citrate by UV Spectrophotometric Method in Pharmaceutical Dosage Form
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(7):108-112 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Dissolution Study of Oxolamine Citrate by UV Spectrophotometric
More informationResearch Article DESIGN AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF THEOPHYLLINE USING NATURAL POLYMERS
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2013, Vol. 2, No.6, pp 721-725 ISSN: 2278-0238 Research Article
More informationSimultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms
Research Paper www.ijpsonline.com Simultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms S. V. CHAUDHARI, ASHWINI KARNIK, ANURADHA ADHIKARY,
More information104 Full Text Available On Research Article!!! Pharmaceutical Sciences. Received: ; Accepted:
International Journal of Institutional Pharmacy and Life Sciences 2(2): March-April 2012 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationInternational Journal of Medicine and Health Profession Research
Research Article ISSN: 2394 7403 International Journal of Medicine and Health Profession Research Journal home page: www.ijmhpr.com FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING SUSTAINED RELEASED
More informationDesign and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets
ORIGINAL ARTICLE Design and In Vitro Characterization of Dexlansoprazole Controlled Release Tablets Y. Naveen Kumar 1, J. Sreekanth 2, P. Vijay Chander Reddy 3 1 Drugs Control Administration, Hyderabad,
More informationS.Janakidevi et al. Int. Res. J. Pharm. 2014, 5 (7) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article DESIGN AND OPTIMIZATION OF CEFIXIME TRIHYDRATE SUSTAINED RELEASE MATRIX TABLETS USING DIFFERENT POLYMERS S.Janakidevi*,
More informationInternational Journal of Pharma and Bio Sciences
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE PHARMACEUTICAL ANALYSIS DEVELOPMENT, ESTIMATION AND VALIDATION OF BOSENTAN IN BULK AND IN ITS PHARMACEUTICAL FORMULATION BY UV-VIS SPECTROSCOPIC
More informationPRACTICAL APPROACH FOR THE ESTIMATION OF ALCOHOL DRUG RELEASE FROM THE SUSTAINED RELEASE DOSAGE FORMS OF VERAPAMIL HYDROCHLORIDE
295 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 4(6): November-December 2015 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY
More informationFormulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps
Formulation and in-vitro Evaluation of Captopril Floating Matrix Tablets Using HPMC 50cps Basawaraj S.Patil*, Sandeep J. Sonawane, Upendra Kulkarni, Hariprasanna R.C. PG Department of Pharmaceutics, R.M.E.S
More informationFormulation development and evaluation of glyburide beads for controlled release
Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 213, 5 (3):17-177 (http://scholarsresearchlibrarycom/archivehtml) ISSN 975-571 USA CODEN: DPLEB4 Formulation
More informationAvailable online through ISSN
Research Article Available online through www.ijrap.net ISSN 2229-3566 COMPARISON OF IN VITRO DISSOLUTION PROFILES OF CEFPODOXIME PROXETIL - PEG SOLID DISPERSIONS WITH CEPODOXIME PROXETIL Madgulkar Ashwini
More informationSpectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form
Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form Kailash P Prajapati *, A Bhandari INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES ISSN 2249-1023 Faculty of Pharmaceutical
More informationMd.Khairul Alam et al / Journal of Pharmaceutical Science and Technology Vol. 3 (6), 2011,
STUDY OF DISSOLUTION IMPROVEMENT OF VARIOUS POORLY WATER SOLUBLE DRUGS BY SOLID DISPERSION MIXING WITH HPMC 6CPS AND PEG 6 Md. Khairul Alam 1 *, Reza-ul Jalil 2, Nazia Zaman 1, Md. SM Ashraful Islam 3
More informationIMPROVEMENT OF DISSOLUTION PROFILE OF LORNOXICAM BY SOLID DISPERSION USING SPRAY DRYING TECHNIQUE
66 P a g e International Standard Serial Number (ISSN): 2319-8141 International Journal of Universal Pharmacy and Bio Sciences 3(5): September-October 2014 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND
More informationInternational Journal of Pharma and Bio Sciences
International Journal of Pharma and Bio Sciences PREPARATION AND EVALUATION OF MICROPOROUS DRUG DELIVERY SYSTEM GOWDA.D.V., KHAN M. S*, NAWAZ MOHAMMED AND SHIVAKUMAR H.G. Department of Pharmaceutics, J.S.S.College
More informationInternational Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016
International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: 097-30, ISSN(Online): 255-9563 Vol.9, No.7, pp 399-06, 2016 Analytical Quality by Design Approach for Development of UV-Spectrophotometric
More informationAtenolol Press Coated (HE) Tablet
CHAPTER 6: FORMULATION AND EVALUATION OF ATENOLOL PULSATILE PRESS COATED TABLETS USING RUPTURABLE AND ERODIBLE POLYMERS 6.1. INTRODUCTION AND AIM OF THE STUDY In order to achieve the chronopharmaceutical
More informationCHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS
55 CHAPTER - 5 DEVELOPMENT AND EVALUATION OF ALFUZOSIN ER TABLETS 5.1 MATERIALS AND EQUIPMENTS Table 5.1: List of materials used in research work Name of the Material Manufacturer Alfuzosin Hydrochloride
More informationMouth Disintegrating Tablets of Taste-Masked Ondansetron HCl
Asian Journal of Chemistry Vol. 19, No. 5 (2007), 3455-3460 Mouth Disintegrating Tablets of Taste-Masked Ondansetron HCl V.K. CHATAP, D.K. SHARMA*, ANIL MIDDHA, R.D. GUPTA, VIPIN SAINI, MAHENDRA SHIRADKAR
More informationReceived 25 March, 2010; received in revised form 03 June, 2010; accepted 15 June, 2010
ISSN: 0975-8232 IJPSR (2010), Vol. 1, Issue 7 (Research Article) Received 25 March, 2010; received in revised form 03 June, 2010; accepted 15 June, 2010 IMPROVEMENT OF DISSOLUTION BEHAVIOR OF PARACETAMOL
More informationCHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs
CHAPTER - 3 ANALYTICAL PROFILE 3.1 Estimation of Drug in Pharmaceutical Formulation 3.1.1 Estimation of Drugs ANALYTICAL PROFILE 84 3.1 ESTIMATION OF DRUG IN PHARMACEUTICAL FORMULATION. Agrawal A et al
More informationCOMPARATIVE EVALUATION OF SOLUBILITY AND DISSOLUTION ENHANCEMENT OF BICALUTAMIDE SOLID BY DISPERSION TECHNIQUE
COMPARATIVE EVALUATION OF SOLUBILITY AND DISSOLUTION ENHANCEMENT OF BICALUTAMIDE SOLID BY DISPERSION TECHNIQUE Katare M. Kumar 1*, Jain A. Pal 2 and Kohli S 3 1. Shri Ram Institute of Technology (Pharmacy),
More informationIndian Journal of Research in Pharmacy and Biotechnology
Formulation and evaluation of enteric coated sustained release matrix tablets of Duloxetine hydrochloride A.Bharathi*, P.Rama Chandra rao, V.Aswini priya, N.Anusha Department of Pharmaceutical Sciences,
More informationReceived: ; Accepted:
International Journal of Universal Pharmacy and Bio Sciences 1(2): November-December2012 INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationImpact factor: 3.958/ICV: 4.10 ISSN:
Impact factor: 3.958/ICV: 4.10 ISSN: 0976-7908 99 Pharma Science Monitor 9(4), Oct-Dec 2018 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com
More informationScholars Research Library. Innovation on Development and Evaluation of Gastric Oral Floating Capsules Containing Captopril
Available online at www.scholarsresearchlibrary.com Der Pharmacia Lettre, 2011, 3(3): 103-109 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 Innovation on Development
More informationSolubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible Spectrophotometer
ISSN: 973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net 28, 5(S2), 1159-1164 Solubility and Dissolution Rate Determination of Different Antiretroviral Drugs in Different ph Media Using UV Visible
More informationFORMULATION AND EVALUATION OF FAST DISSOLVING CHLORTHALIDONE TABLETS
International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 1, Suppl 1, Nov.-Dec. 2009 Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING CHLORTHALIDONE TABLETS RAGHAVENDRA RAO N.G
More informationFormulation development and evaluation of sustained release matrix tablets of quetiapine fumarate
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(4):628-632 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Formulation development and evaluation of sustained
More informationDicyclomine-loaded Eudragit -based Microsponge with Potential for Colonic Delivery: Preparation and Characterization
Tropical Journal of Pharmaceutical esearch, February 2010; 9 (1): 67-72 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. esearch Article
More informationInternational Journal of Innovative Pharmaceutical Sciences and Research
International Journal of Innovative Pharmaceutical Sciences and Research www.ijipsr.com FORMULATION AND EVALUATION OF MONTLUKAST SODIUM EXTENDED RELEASE MATRIX TABLET 1 G.Rajini*, 2 Dr N. Srinivas Malla
More informationImpact factor: /ICV: PROCESS VALIDATION OF PARACETAMOL SUSPENSION Sisal Shah*, Dinesh G. Desai, A. K.
Impact factor:.3397/icv: 4. 299 Pharma Science Monitor 6(2), Apr-Jun 25 PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES Journal home page: http://www.pharmasm.com PROCESS VALIDATION
More informationJournal of Chemical and Pharmaceutical Research, 2012, 4(3): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(3):1573-1579 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 In vitro release kinetic study of ambroxol hydrochloride
More informationDISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC AND THEIR COMBINATIONS AS DISPERSION CARRIERS
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.1, pp 480-484, Jan-Mar 2010 DISSOLUTION PROFILLING OF NIMESULIDE SOLID DISPERSIONS WITH POLYETHYLENE GLYCOL, TALC
More informationJ Pharm Sci Bioscientific Res (4): ISSN NO
Development and Validation of Stability Indicating Analytical Method for Simultaneous Estimation of Perindopril and Potassium in Their Combined Marketed Dosage Form ABSTRACT: Gurjeet Kaur*, Nikhil Patel
More informationDevelopment and Validation of Stability Indicating Assay Method of Etodolac by using UV-Visible Spectrophotometer
Research Article Development and Validation of Stability Indicating Assay Method of Etodolac by using UV-Visible Spectrophotometer Aniruddha J Palande, Shailaja B Jadhav *, Amit S Tapkir, Pravin D Chaudhari,
More information8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES
8. FORMULATION OF LANSOPRAZOLE NANOPARTICLES FORMULATION OF LANSOPRAZOLE NANOPARTICLES Preparation of capsule of modified solubility to protect the drug from degradation To protect the drug from degradation
More informationSimultaneous Estimation Of Paracetamol And Pamabrom Inbulk Drugs And In Pharmaceutical Formulation By Spectrophotometry
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.5, No.4, pp 1802-1807, April-June 2013 Simultaneous Estimation Of Paracetamol And Pamabrom Inbulk Drugs And In Pharmaceutical
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com FORMULATION, OPTIMIZATION AND INVITRO EVALUATION OF
More informationIN VITRO DISSOLUTION KINETIC STUDY OF THEOPHYLLINE FROM HYDROPHILIC AND HYDROPHOBIC MATRICES
Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 63 No. 1 pp. 63ñ67, 2006 ISSN 0001-6837 Polish Pharmaceutical Society IN VITRO DISSOLUTION KINETIC STUDY OF THEOPHYLLINE FROM HYDROPHILIC AND HYDROPHOBIC
More informationThe Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems
METHOCEL Application Data Premium Cellulose Ethers The Influence of Hydro-Alcoholic Media on Hypromellose Matrix Systems OBJECTIVES The hydrophilic matrices (HM) continue to be a popular and widely used
More information*Author for Correspondence
DEVELOPMENT AND VALIDATION OF A SIMPLE UV SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF URAPIDIL HYDROCHLORIDE BOTH IN BULK AND PHARMACEUTICAL FORMULATION *S. Navgire 1, A. Ghadge 2, S. Gurav 2, S.
More informationAREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION
Int. J. Chem. Sci.: 8(2), 2010, 823-827 AREA UNDER CURVE AND SECND RDER DERIVATIVE SPECTRSCPY F METAXALNE IN BULK DRUG AND TABLET FRMULATIN J. PRIYADHARISINI, G. P. GIGI, V. NIRAIMATHI and A. JERAD SURESH
More informationSimultaneous Determination of Ramipril, Hydrochlorothizide and Telmisartan by Spectrophotometry
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.1, No.2, pp 183-188, April-June 2009 Simultaneous Determination of Ramipril, Hydrochlorothizide and Telmisartan by Spectrophotometry
More informationChapter 4: Verification of compendial methods
Chapter 4: Verification of compendial methods Introduction In order to ensure accurate and reliable test results, the quality control laboratory (QCL) needs to use analytical methods (and accompanying
More informationInt. J. Pharm. Sci. Rev. Res., 31(2), March April 2015; Article No. 26, Pages:
Research Article Y. Ganesh Kumar* 1, J. Sreekanth 2, D. Satyavati 3 1 Research Scholar, Faculty of Pharmaceutical Sciences, JNTU, Kukatpally, Hyderabad, Telangana, India. 2 Sr. General Manager, R&D Center,
More informationFORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE
ISSN 976 44X Research Article FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF GLICLAZIDE Ch.T.Lalitha kumari*, Dr.M.Mohan Varma, P.Satish Kumar, N. Jahnavi Shri Vishnu College of Pharmacy, Vishnupur,
More informationImpact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets
Impact of Granulation and Effect of Polymers on Theophylline Release from Matrix Tablets Kazi Rashidul Azam, Md. Shaikhul Millat Ibn Razzak, Ferdous Khan, Muhammad Shahidul Islam, Md. Ruknuzzaman Rony
More informationFORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF REPAGLINIDE FAST DISSOLVING TABLETS Chirravuri S Phani Kumar
More informationFormulation development and In-Vitro evaluation of floating tablets of Cefixime
48 Formulation development and In-Vitro evaluation of floating tablets of Cefixime B. Venkateswara Reddy Department of Pharmaceutics, St. Pauls College of Pharmacy, Hayathnagar, R.R. Dist, India basu.pharmacist@gmail.com
More informationDEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR CLOPIDOGREL BISULFATE IN BULK AND FORMULATIONS
Int. J. Chem. Sci.: 10(1), 2012, 449-456 ISSN 0972-768X www.sadgurupublications.com DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR CLOPIDOGREL BISULFATE IN BULK AND FORMULATIONS PRAVIN CHOLKE
More informationSpectrophotometric estimation and validation of hydrochlorothiazide in tablet dosage forms by using different solvents
Available online at www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2012, 4 (1):10-14 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Spectrophotometric
More informationEffect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets
Effect of Alkaline Excipients on The Release Profile of Gliclazide Extended Release Tablets Monika Srivastav 1, B Prabhakar 1, Ashok Omray 2 1 School of Pharmacy & Technology Management, NMIMS University,
More informationDevelopment and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method
21 Article Development and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method Mali Audumbar Digambar*, Jadhav Santosh, Mane Pandurang,
More informationResearch Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation
Research Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation RN. Kane, PS. Bhokare*, CC. Nalawade, MS Sayyed and RD. Paliwal Department of Pharmaceutical Chemistry, Singhad
More informationCHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)
CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC A UV spectrophotometric method based on the measurement of absorbance at 276nm in phosphate buffer of p H 7.4 was used in the present study of the
More informationDETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
CHAPTER 9 DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY CHAPTER 9 Determination of drug release during
More informationFormulation and evaluation of doxycycline hydrochloride delayed release enteric coated tablets
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2012, 4 (1): 249-255 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More informationFORMULATION AND EVALUATION OF SOLID DISPERSIONS OF CARVEDILOL, A POORLY WATER SOLUBLE DRUG BY USING DIFFERENT POLYMERS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF SOLID DISPERSIONS OF CARVEDILOL, A POORLY WATER SOLUBLE DRUG
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES
Research Article An In-Vitro Evaluation for the Effect of Β-Cyclodextrin and PVP-K 3 on Drug Release Pattern of Sertraline Hydrochloride Deepa Warrier 1, Aanna Zagade 1, Amir Shaikh 2*, Yogesh Pawar 2
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF LURASIDONE HCl MS. MANSI M. SONI 1,2, DR. KANU R. PATEL 2 1. Research scholar, Gujarat
More informationDevelopment and validation of second order derivative methods for quantitative estimation of clopidogrel in bulk and pharmaceutical dosage form
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2014, 6 (6):117-121 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
More information5. PREFORMULATION STUDY
5. PREFORMULATION STUDY Preformulation studies are the first step in the rational development of dosage form of a drug substance. The work was conducted by using Losartan Potassium as a model drug. The
More informationInternational Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research
G. Archana et al, IJCTPR, 2016, 4(2): 91 99 CODEN (USA): IJCTGM ISSN: 2321-3760 International Journal of Current Trends in Pharmaceutical Research Journal Home Page: www.pharmaresearchlibrary.com/ijctpr
More informationSIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD
Int. J. Chem. Sci.: 6(3), 2008, 1377-1384 SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD JAYESH V. PATEL, C. N. PATEL, P. U. PATEL a PANKAJ H. PRAJAPATI, I. S.
More informationCHAPTER 7 SUMMARY AND CONCLUSIONS. constitutes the objective of many a research project in the field of pharmaceutical
CHAPTER 7 SUMMARY AND CONCLUSIONS Taste masking and development of palatable dosage forms of bitter drugs constitutes the objective of many a research project in the field of pharmaceutical technology.
More informationCHAPTER.6 FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF ONDANSETRON HCl
CHAPTER.6 FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF ONDANSETRON HCl 6.1 Taste making of ondansetron HCl 6.1.1 Development and characterization of taste masked granules of ondansetron HCl
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Formulation and Development of ph Independent Once Daily Matrix Tablet of Quetiapine Fumarate R Mohapatra* 1, S Senapati 1, C Sahoo
More informationOndansetron hydrochloride (OSH) is an effective
dx.doi.org/10.14227/dt200413p34 In Vitro Dissolution Enhancement of Ondansetron by Solid Dispersion in Superdisintegrants e-mail: rkpharma26@yahoo.co.in Rajnikant M. Suthar 1, *, Narendra P. Chotai 1,
More informationSimultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID
Asian Journal of Chemistry Vol. 21, No. 3 (2009), 1739-1746 Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID PRAVEEN KUMAR BALIYAN*, R.P.
More informationINTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES
International Journal of Institutional Pharmacy and Life Sciences 6(2): March-April 2016 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!! Received:
More informationFormulation Design And Invitro Evaluation Of Sustained Release Matrix Tablets Of Losartan Potassium Using HPMC Polymers
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.3, pp 1332-1344, July-Sept 2013 Formulation Design And Invitro Evaluation Of Sustained Release Matrix Tablets
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Research Article CODEN: IJRPJK ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com FORMULATION AND EVALUATION OF GASTRORETENTIVE CIPROFLOXACIN
More informationDesign and evaluation of a Sustained Release Gastroretentive Dosage form of Captopril
December - January, 2017; 6(2): 2535-2547 International Journal of Research and Development in Pharmacy & Life Science An International Open access peer reviewed journal ISSN (P): 2393-932X, ISSN (E):
More informationZero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation
International Journal of PharmTech Research CDEN (USA): IJPRIF ISSN : 0974-4304 Vol.5, No.1, pp 217-221, Jan-Mar 2013 Zero And First rder Derivative Spectrophotometric Methods For Determination f Dronedarone
More information4.4.1 Formulation of Non-Effervescent floating tablets Formulation of Effervescent floating tablets Formulation of Hollow microspheres
4.1 Materials 4.2 Instruments and Equipments 4.3 Analytical Methods 4.4 Formulations 4.4.1 Formulation of Non-Effervescent floating tablets 4.4.2 Formulation of Effervescent floating tablets 4.4.3 Formulation
More informationQuality by design (QbD) is an intelligent
ORIGINAL ARTICLE Quality by Design-based Formulation and Evaluation of Fast Dissolving Tablet of Aspirin R. N. Mali, S. R. Desai, J.I. Disouza Department of Quality Assurance, Tatyasaheb Kore College of
More informationIAJPS 2016, 3 (6), Naresh N S and Pratyusha A ISSN Available online at:
CODEN (USA): IAJPBB ISSN: 2349-7750 INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES Available online at: http://www.iajps.com Research Article FORMULATION DESIGN AND EVALUATION OF SAXAGLIPTIN SUSTAINED
More information1. Preliminary qualitative analysis of unknown substances (liquid or solid).
Name of Procedure: Ultraviolet Spectroscopy Suggested Uses: 1. Preliminary qualitative analysis of unknown substances (liquid or solid). 2. Quantitative analysis of known compounds. Apparatus Used to Perform
More informationPreparation and In-Vitro Evaluation of Donepezil Hydrochloride Sustained Release Matrix Tablets Using Non-Gelling Polymer
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-3008, p-issn:2319-7676. Volume 9, Issue 5 Ver. IV (Sep -Oct. 2014), PP 83-91 Preparation and In-Vitro Evaluation of Donepezil Hydrochloride
More informationValidated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.3, No.1, pp 18-22, Jan-Mar 2011 Validated First Order Derivative Spectroscopic Method for the determination of Stavudine
More informationNew Derivative Spectrophotometric Methods for the Determination of Fluoxetine - An Antidepressant Drug
Chem Sci Trans., 2012, 1(3), 697-701 Chemical Science Transactions DOI:10.7598/cst2012.225 ISSN/E-ISSN: 2278-3458/2278-3318 RESEARCH ARTICLE New Derivative Spectrophotometric Methods for the Determination
More informationFormulation and Evaluation of Release-Retardant Matrix Tablets of Diclofenac Sodium
FABAD J. Pharm. Sci., 31, 119-16, 006 RESEARCH ARTICLE Formulation and Evaluation of Release-Retardant Matrix Tablets of Diclofenac Sodium Sunita DAHIYA*, Formulation and Evaluation of Release-Retardant
More informationEstimation of Dapagliflozin from its Tablet Formulation by UV-Spectrophotometry
Pharm Methods, 2017; 8(2): 102-107 A multifaceted peer reviewed journal in the field of Pharm Analysis and Pharmaceutics www.phmethods.net www.journalonweb.com/phm Original Article Estimation of Dapagliflozin
More informationDEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION
Page186 Research Article Pharmaceutical Sciences DEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION Kishore Konam 1 &
More informationSimultaneous Estimation of Metolazone and Spironolactone in Combined Tablet Dosage Form BY UV Spectroscopy.
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.3, No.4, pp 2068-2074, Oct-Dec 2011 Simultaneous Estimation of Metolazone and Spironolactone in Combined Tablet Dosage
More informationPlop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest)
Page 1 of 7 Plop Plop, Fizz Fizz, Oh What A Relief It Is (Which Pain Reliever Works Fastest) Learning Objectives: Study the dissolution rate (how quickly the compound dissolves) of common OTC (over the
More informationDissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form
Research Journal of Recent Sciences ISSN 2277-252 Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form Abstract Rele Rajan
More informationInternational Journal of Chemistry and Pharmaceutical Sciences. International Journal of Chemistry and Pharmaceutical Sciences
D. Nirmala Kumari et al, IJCPS, 2015, 3(5): 1678 1683 ISSN: 2321-3132 International Journal of Chemistry and Pharmaceutical Sciences Journal Home Page: www.pharmaresearchlibrary.com/ijcps Research Article
More informationQuantitative analysis method development and validation for Irbesartan in bulk drug by Ultraviolet spectroscopy
Research Article Quantitative analysis method development and validation for Irbesartan in bulk drug by Ultraviolet spectroscopy Amit Asati 2 *, Anita Shinde, Suman Malik 2, K. C. Asati Department of Chemistry
More informationFormulation and Evaluation of Mucoadhesive Microspheres of Amoxicillin Trihydrate by using Eudragit RS 100
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 0974-4290 Vol.2, No.1, pp 466-470, Jan-Mar 2010 Formulation and Evaluation of Mucoadhesive Microspheres of Amoxicillin Trihydrate by
More informationFormulation and Evaluation of Extended Release Tablets containing Metformin HCl
International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : 974-429 Vol.2, No.2, pp 132-1329, April-June 21 Formulation and Evaluation of Extended Release Tablets containing Metformin HCl Margret
More information